BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16343438)

  • 1. FHL2 mediates p53-induced transcriptional activation through a direct association with HIPK2.
    Lee SW; Kim EJ; Um SJ
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1056-62. PubMed ID: 16343438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
    Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
    EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
    Pierantoni GM; Fedele M; Pentimalli F; Benvenuto G; Pero R; Viglietto G; Santoro M; Chiariotti L; Fusco A
    Oncogene; 2001 Sep; 20(43):6132-41. PubMed ID: 11593421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mapping of FHL2 transcription activation domain].
    Yan JH; Ye QN; Fang Y; Zhu JH; Huang CF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):643-8. PubMed ID: 12883635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.
    Li Q; Wang X; Wu X; Rui Y; Liu W; Wang J; Wang X; Liou YC; Ye Z; Lin SC
    Cancer Res; 2007 Jan; 67(1):66-74. PubMed ID: 17210684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.
    Labalette C; Renard CA; Neuveut C; Buendia MA; Wei Y
    Mol Cell Biol; 2004 Dec; 24(24):10689-702. PubMed ID: 15572674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XIAP-associated factor 1 interacts with and attenuates the trans-activity of four and a Half LIM protein 2.
    Zhang W; Yang Y; Jiang B; Peng J; Tu S; Sardet C; Zhang Y; Pang R; Hung IF; Tan VP; Lam CS; Wang J; Wong BC
    Mol Carcinog; 2011 Mar; 50(3):199-207. PubMed ID: 21104993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of aryl hydrocarbon receptor activity by four and a half LIM domain 2.
    Kollara A; Brown TJ
    Int J Biochem Cell Biol; 2009 May; 41(5):1182-8. PubMed ID: 19015043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
    Puca R; Nardinocchi L; Gal H; Rechavi G; Amariglio N; Domany E; Notterman DA; Scarsella M; Leonetti C; Sacchi A; Blandino G; Givol D; D'Orazi G
    Cancer Res; 2008 May; 68(10):3707-14. PubMed ID: 18483253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the heart-specific LIM domain protein, FHL2, with DNA-binding nuclear protein, hNP220.
    Ng EK; Chan KK; Wong CH; Tsui SK; Ngai SM; Lee SM; Kotaka M; Lee CY; Waye MM; Fung KP
    J Cell Biochem; 2002; 84(3):556-66. PubMed ID: 11813260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc.
    Puca R; Nardinocchi L; Bossi G; Sacchi A; Rechavi G; Givol D; D'Orazi G
    Exp Cell Res; 2009 Jan; 315(1):67-75. PubMed ID: 18996371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4.
    Yamada D; PĂ©rez-Torrado R; Filion G; Caly M; Jammart B; Devignot V; Sasai N; Ravassard P; Mallet J; Sastre-Garau X; Schmitz ML; Defossez PA
    Oncogene; 2009 Jul; 28(27):2535-44. PubMed ID: 19448668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
    Kleiber K; Strebhardt K; Martin BT
    Anticancer Res; 2007; 27(1A):55-61. PubMed ID: 17352216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA.
    Nardinocchi L; Puca R; Sacchi A; D'Orazi G
    Biochem Biophys Res Commun; 2007 Sep; 361(1):249-55. PubMed ID: 17658469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-protein interaction of FHL2, a LIM domain protein preferentially expressed in human heart, with hCDC47.
    Chan KK; Tsui SK; Ngai SM; Lee SM; Kotaka M; Waye MM; Lee CY; Fung KP
    J Cell Biochem; 2000 Jan; 76(3):499-508. PubMed ID: 10649446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
    Kim EJ; Park JS; Um SJ
    J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET).
    Li HY; Ng EK; Lee SM; Kotaka M; Tsui SK; Lee CY; Fung KP; Waye MM
    J Cell Biochem; 2001; 80(3):293-303. PubMed ID: 11135358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis.
    Puca R; Nardinocchi L; Starace G; Rechavi G; Sacchi A; Givol D; D'Orazi G
    Free Radic Biol Med; 2010 May; 48(10):1338-46. PubMed ID: 20171273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.